title: Xeomin(®)  use in patients with systemic immune reactions to other botulinum toxins type A.
authors: Department of Neurology, Catholic University of Sacred Heart, Rome, Italy.|Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
authors: L
authors: L
authors: Ricciardi
authors: Department of Neurology, Catholic University of Sacred Heart, Rome, Italy.
authors: F
authors: F
authors: Bove
authors: Department of Neurology, Catholic University of Sacred Heart, Rome, Italy.
authors: A
authors: A
authors: Fasano
mesh_terms: D000368:Aged; D019274:Botulinum Toxins, Type A / Q000009:adverse effects* / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D014103:Torticollis / Q000188:drug therapy*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; C545476:incobotulinumtoxinA